Delivery Order SPE2DB22D3019-SPE2DB26FK2UA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,873.85 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on November 10, 2025, with an ultimate completion date of November 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,301.47 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price delivery order represents a non-set-aside award made through open competition and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Jardiance 10 mg tablets (90-count) valued at $11,906.66. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. The order is due for completion by November 13, 2025, and will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $11,396.56 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages). This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by November 17, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance, leveraging the company's position as a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $17,047.57 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on November 12, 2025, with completion scheduled for November 13, 2025. This competitively awarded, firm fixed-price delivery order represents a direct fulfillment of pharmaceutical needs through AmerisourceBergen's existing contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a $10,781.30 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Jardiance 25 mg tablets (90-count packages). This firm fixed-price contract, with an ultimate completion date of July 25, 2025, represents a single delivery order under the company's broader pharmaceutical supply agreement. The award utilizes no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a contract value of $7,423.84. This non-set-aside, competitively awarded delivery order carries a firm fixed price structure and is scheduled for completion by November 13, 2025. The order will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a routine...
- The Defense Logistics Agency awarded a delivery order valued at $13,309.50 to AmerisourceBergen Drug Corp for 90-count packages of Jardiance 25 mg tablets on November 13, 2025, with completion targeted for November 14, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $5,288.69 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on July 2, 2025, with an ultimate completion date of July 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a single pharmaceutical fulfillment under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) with a ceiling value of $97,854.10. This firm fixed-price delivery order, with an ultimate completion date of November 7, 2025, represents a pharmaceutical supply requirement for federal medical procurement. The award was made on a competitive basis without set-aside designation, and the place of performance is AmerisourceBergen's...
- SPE2DB22D3019Indefinite Delivery Contract
- SPE2DB22D3019-SPE2DB26FK2UADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,257.83 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on November 5, 2025, with completion scheduled for November 6, 2025. This firm fixed-price, competitively awarded delivery order was issued without set-aside designation and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction under the Defense Logistics Agency's medical procurement operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical prime vendor supporting federal medical procurement needs across military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver a comprehensive range of pharmaceutical products, medical supplies, and specialized healthcare commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.3k | 11/5/25 |